(Q24791545)

English

Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation

scientific article

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation (English)

0 references

type 2 diabetes

0 references

metabolic syndrome

1 reference

based on heuristic

inferred from title

reactive oxygen species

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Melvin R Hayden

1

object named as

Melvin R Hayden

0 references

2

object named as

Suresh C Tyagi

0 references

language of work or name

0 references

publication date

10 May 2004

0 references

Nutrition Journal

0 references

3

0 references

1

0 references

4

0 references

Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

7 April 2017

Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

7 April 2017

Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

7 April 2017

Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

7 April 2017

Update on cobalamin, folate, and homocysteine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

7 April 2017

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

7 April 2017

The metabolism of homocysteine: pathways and regulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

7 April 2017

Metformin-Associated Vitamin B12 Deficiency

1 reference

https://api.crossref.org/works/10.1186/1475-2891-3-4

22 April 2017

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

7 April 2017

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

7 April 2017

Effect of pharmacological treatments for diabetes on homocysteine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Methods in assessing homocysteine metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Methionine metabolism in mammals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Myocardial redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and congestive heart failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Total plasma homocysteine and restenosis after percutaneous coronary angioplasty: current evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? 2. Epidemiological data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Role of nitric oxide in matrix remodeling in diabetes and heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Insulin resistance and endothelial dysfunction in atherosclerosis: implications and interventions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Physiology of folic acid in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Folates and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Homocysteine and cardiovascular disease in diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

PPAR-gamma effects on the vasculature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Consequences of homocysteine export and oxidation in the vascular system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Roles of PPARs in health and disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Atherogenesis and the homocysteine-folate-cobalamin triad: do we need standardized analyses?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Polynitrosylated proteins: characterization, bioactivity, and functional consequences.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Diabetes and cardiovascular disease. The "common soil" hypothesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Generation of superoxide free radical during the autoxidation of thiols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 September 2017

Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

30 May 2018

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

30 May 2018

Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

30 May 2018

Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

30 May 2018

Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Effect of elevated homocysteine levels on clinical restenosis following percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Relation of homocysteine, vitamin B(12), and folate to coronary in-stent restenosis

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Secondary prevention with folic acid: effects on clinical outcomes

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study.

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Induction of oxidative stress by homocyst(e)ine impairs endothelial function

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Association of eNOS Glu298Asp polymorphism with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Genetic evidence that nitric oxide modulates homocysteine: the NOS3 894TT genotype is a risk factor for hyperhomocystenemia

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in Zucker rats

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor-γ Agonist in Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Epidemiology of homocysteine as a risk factor in diabetes

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Hormonal regulation of homocysteine

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Lifestyle, homocysteine, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Management of hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

21 January 2018

Homocysteine level and other biochemical parameters in cardiovascular disease patients with diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 November 2018

Should we screen diabetic patients using biguanides for megaloblastic anaemia?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 November 2018

Interrelationship of homocysteine-cobalamin-folate indices in human subjects of various ages: can hyper-homocyteinemia be relieved with B-12 supplementation?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 November 2018

Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 November 2018

Homocysteine and restenosis after percutaneous coronary intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 November 2018

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420478

28 November 2018

Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing plasma homocysteine levels in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of homocysteine on endothelial nitric oxide production

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperhomocyst(e)inemia induces multiorgan damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional and structural changes in the kidney in the early stages of obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using Title IIIc nutrition services

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-reactive protein, inflammation, and coronary risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum total homocysteine and coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homocysteine and atherothrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperhomocysteinemia and the metabolic syndrome: is there a connection?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperhomocysteinemia and cardiovascular disease: new mechanisms beyond atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15134582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On evolutionary biology, inflammation, infection, and the causes of atherosclerosis

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-3-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1186/1475-2891-3-4

0 references

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1475-2891-3-4

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24791545&oldid=2176849908"